Bonnee Rubinfeld
- Molecular Biology top 0.5%
- Wnt/β-catenin signaling in development and cancer 22
- Cancer-related gene regulation 19
- Protein Kinase Regulation and GTPase Signaling 10
- Ubiquitin and proteasome pathways 4
- Cell Biology top 0.5%
- Pathology and Forensic Medicine top 0.5%
- Genetic factors in colorectal cancer 7
- Oncology top 1%
- HER2/EGFR in Cancer Research 6
- Cancer-related Molecular Pathways 6
- Immunology and Allergy top 2%
-
- Monoclonal and Polyclonal Antibodies Research 6
Bonnee Rubinfeld
48 papers receiving 10.0k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Molecular Biology 8.7k
- Cell Biology 1.4k
- Pathology and Forensic Medicine 1.5k
- Oncology 2.0k
- Immunology and Allergy 322
Countries citing papers authored by Bonnee Rubinfeld
This map shows the geographic impact of Bonnee Rubinfeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bonnee Rubinfeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bonnee Rubinfeld more than expected).
Fields of papers citing papers by Bonnee Rubinfeld
This network shows the impact of papers produced by Bonnee Rubinfeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bonnee Rubinfeld. The network helps show where Bonnee Rubinfeld may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bonnee Rubinfeld, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 18 | |
| 2 | 2013 | 51 | |
| 3 | 2010 | 173 | |
| 4 | 2007 | 117 | |
| 5 | Armed antibodies targeted to STEAP1 inhibit growth of human prostate xenografts in vivo | 2007 | 1 |
| 6 | 2006 | 49 | |
| 7 | 2000 | 56 | |
| 8 | The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumorsbreakdown → | 1999 | 581 |
| 9 | The F-box protein β-TrCP associates with phosphorylated β-catenin and regulates its activity in the cellbreakdown → | 1999 | 579 |
| 10 | 1999 | 66 | |
| 11 | 1997 | 133 | |
| 12 | 1996 | 287 | |
| 13 | 1996 | 46 | |
| 14 | 1995 | 69 | |
| 15 | 1995 | 3 | |
| 16 | 1994 | 6 | |
| 17 | 1992 | 11 | |
| 18 | 1991 | 8 | |
| 19 | 1991 | 218 | |
| 20 | 1986 | 8 |
About Bonnee Rubinfeld
Bonnee Rubinfeld is a scholar working on Molecular Biology, Oncology, Cell Biology, Pathology and Forensic Medicine and Immunology and Allergy, having authored 49 papers that have together received 10.3k indexed citations. Recurring topics across this work include Wnt/β-catenin signaling in development and cancer (22 papers), Cancer-related gene regulation (19 papers), Protein Kinase Regulation and GTPase Signaling (10 papers), Genetic factors in colorectal cancer (7 papers), HER2/EGFR in Cancer Research (6 papers), Cancer-related Molecular Pathways (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Ubiquitin and proteasome pathways (4 papers). The work is most often cited by research in Molecular Biology (8.7k citations), Cell Biology (1.4k citations), Pathology and Forensic Medicine (1.5k citations), Oncology (2.0k citations) and Immunology and Allergy (322 citations). Bonnee Rubinfeld has collaborated with scholars based in United States, Japan and Australia. Frequent co-authors include Paul Polakis, Iris Albert, S Munemitsu, Emilio Porfiri, Brígida Souza, Matthew J. Hart, Brian Souza, Carol J. Fiol, Frank McCormick and Oliver Müller. Their work appears in journals such as Journal of Biological Chemistry, Molecular and Cellular Biology, Science, Cancer Research and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.